Samoa Digital Library

An Assessment of Distress Levels of Patients Undergoing Lung Cancer Q1 Treatment and Surveillance During the COVID-19 Pandemic

Show simple item record

dc.contributor.author Albano, Denise
dc.contributor.author Feraca, Melissa
dc.contributor.author Nemesure, Barbara
dc.date.accessioned 2020-11-23T00:06:56Z
dc.date.available 2020-11-23T00:06:56Z
dc.date.issued 2020
dc.identifier.uri ${sadil.baseUrl}/handle/123456789/110
dc.description 3 p. ; graph en_US
dc.description.abstract According to the Centers for Disease Control and Prevention, COVID-19 has affected more than Q3 5,119,711 patients with more than 163,651 confirmed deaths reported. The mass media coverage and widespread eruption of illnesses have been associated with adverse mental health outcomes.1 Q4 Cancer patients represent an already- compromised population with elevated levels of anxiety and distress; the introduction of the COVID-19 pandemic places this vulnerable group at an even higher risk for mental health consequences. The purpose of this quality improvement initiative was to identify lung cancer patients in our care who demonstrated increased levels of anxiety and distress directly related to the COVID-19 pandemic and to facilitate the acquisition of appropriate care to address their mental health needs. This initiative was designed to aid in the reduction of stress and anxiety in an already burdened population. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartofseries The Journal for Nurse Practitioners;
dc.subject coronavirus en_US
dc.subject COVID-19 en_US
dc.subject lung cancer treatment en_US
dc.subject mental health screening en_US
dc.title An Assessment of Distress Levels of Patients Undergoing Lung Cancer Q1 Treatment and Surveillance During the COVID-19 Pandemic en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account